$Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”$

Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”

Saved in:

Bibliographic Details
Main Authors:	Thi Ha Chau Tran, Stéphane Dumas, Florence Coscas
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2018/9171269
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
by: Thi Ha Chau Tran, et al.
Published: (2017-01-01)

Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept
by: Juliana Wons, et al.
Published: (2017-01-01)

Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up
by: M. Schoumacher, et al.
Published: (2025-01-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
by: Pedro Neves Cardoso, et al.
Published: (2017-01-01)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
by: Jan Nemcansky, et al.
Published: (2019-01-01)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)

Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
by: Joachim Wachtlin, et al.
Published: (2020-01-01)

Three-Year Outcomes of Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept under the National Health Insurance Program in Taiwan
by: Kang-Jung Lo, et al.
Published: (2020-01-01)

Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
by: Burak Erden, et al.
Published: (2019-01-01)

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease
by: Ning-Yi Hsia, et al.
Published: (2021-01-01)

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
by: Xiaobei Yin, et al.
Published: (2022-01-01)

A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
by: Sophie Seguin-Greenstein, et al.
Published: (2016-01-01)

Assessment of local sensitivity in incomplete retinal pigment epithelium and outer retinal atrophy (iRORA) lesions in intermediate age-related macular degeneration (iAMD)
by: Frank G Holz, et al.
Published: (2024-03-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema
by: Samir M. El-Baha, et al.
Published: (2019-01-01)

Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting
by: Anne Rübsam, et al.
Published: (2022-01-01)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01)

OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review
by: Cristian Metrangolo, et al.
Published: (2021-01-01)

A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study
by: Sergio Pagliarini, et al.
Published: (2014-01-01)

Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis
by: Alessandro Randazzo, et al.
Published: (2021-01-01)

Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration
by: Gábor G. Deák, et al.
Published: (2025-02-01)

Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
by: Alper Bilgic, et al.
Published: (2020-01-01)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
by: O’Sam Shibeeb, et al.
Published: (2014-01-01)

Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
by: Francisco Rodríguez, et al.
Published: (2024-05-01)

Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study
by: Øystein Kalsnes Jørstad, et al.
Published: (2024-12-01)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01)

The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration
by: Daniel Ahmed, et al.
Published: (2021-01-01)

Assessment of retinal pigment epithelium tears in eyes with submacular hemorrhage secondary to age-related macular degeneration
by: Tomoko Ueda-Consolvo, et al.
Published: (2025-01-01)

Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema
by: Ivan Pochou Lai, et al.
Published: (2020-01-01)

Age-Related Macular Degeneration (AMD) Transmitochondrial Cybrids Protected from Cellular Damage and Death by Human Retinal Progenitor Cells (hRPCs)
by: Jeffrey J. Yu, et al.
Published: (2021-01-01)

Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population
by: Kai Fang, et al.
Published: (2015-01-01)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
by: Ana Catarina Pedrosa, et al.
Published: (2017-01-01)

Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
by: Hamid Riazi-Esfahani, et al.
Published: (2025-02-01)

Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study
by: Oliver Zeitz, et al.
Published: (2022-06-01)

Evaluation of Vitrectomy with Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema with or without Vitreomacular Interface Abnormality
by: Ahmed M. Abdel Hadi
Published: (2018-01-01)

Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response—a scoping review
by: Nikolaos Dervenis, et al.
Published: (2024-05-01)

Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration
by: Martin Stattin, et al.
Published: (2019-01-01)